** Shares of dialysis products maker Rockwell Medical RMTI.O rise 16.9% to $2.35 premarket
** Co enters a product purchase agreement for its hemodialysis product, SteriLyte, that is expected to generate upwards of $10 million in net sales in 2025
** Says the agreement has an effective term of up to 5 years, and includes incremental price increases for the product each subsequent year
** Up to last close, stock up 6.4% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))